NCT05455606 2026-01-22
Does the Use of a Genomic Tumor Board Increase the Number of Patients Who Receive Genome-Informed Treatment
SWOG Cancer Research Network
Phase NA Active not recruiting
Clinical Trials
55 trialsNCT06391242 2026-01-21
Stereotactic Body Radiotherapy vs Conventional Palliative Radiotherapy for Painful Non-Spine Bone Metastases
Canadian Cancer Trials Group
Phase 3 Recruiting
NCT02194842 2025-09-19
PEACE III
European Organisation for Research and Treatment of Cancer - EORTC
Phase 3 Active not recruiting
NCT01979393 2025-08-01
IRCI Gynae Sarcomas, High Grade Uterine Sarcoma
European Organisation for Research and Treatment of Cancer - EORTC
Phase 2 Completed
NCT04042051 2025-07-22
Panthera
Cancer Trials Ireland
Phase 1 Terminated
NCT04879368 2025-07-17
INTEGRATEIIb
Australasian Gastro-Intestinal Trials Group
Phase 3 Active not recruiting
NCT00922974 2025-04-29
Image-Guided Radiosurgery or Stereotactic Body Radiation Therapy in Treating Patients With Localized Spine Metastasis
Radiation Therapy Oncology Group
Phase 2/3 Completed
NCT03869762 2024-09-25
DICE
Cancer Trials Ireland
Phase 2 Terminated
NCT02536742 2024-02-26
PYTHIA
ETOP IBCSG Partners Foundation
Phase 2 Completed
NCT02954055 2024-02-26
METEORA-II
ETOP IBCSG Partners Foundation
Phase 2 Completed
NCT03260712 2023-11-03
Pembrolizumab in Biliary Tract Cancer
European Organisation for Research and Treatment of Cancer - EORTC
Phase 2 Completed
NCT00993655 2023-08-28
Intraperitoneal vs Intravenous Chemotherapy Following Neoadjuvant Chemotherapy in Ovarian Cancer
Canadian Cancer Trials Group
Phase 2 Completed
NCT00080912 2023-08-21
Single vs Multiple-Fraction Therapy in Treating Patients With Previously Irradiated Painful Bone Metastases
Canadian Cancer Trials Group
Phase NA Completed
NCT00003907 2023-07-05
Chemoembolization in Treating Patients With Primary Liver Cancer or Metastases to the Liver
Eastern Cooperative Oncology Group
Phase 2 Completed
NCT00080938 2023-06-29
Temozolomide and Radiation Therapy in Treating Patients With Brain Metastasis Secondary to Non-Small Cell Lung Cancer
Eastern Cooperative Oncology Group
Phase 2 Completed
NCT04194528 2023-06-27
S1916 Digital Medicine Program for Pain Control in Cancer Patients
SWOG Cancer Research Network
Phase NA Terminated
NCT00002872 2023-06-22
Bleomycin, Doxycycline, or Talc in Treating Patients With Malignant Pleural Effusions
Eastern Cooperative Oncology Group
Phase 3 Completed
NCT00003308 2023-06-22
Radiation Therapy in Treating Patients With Newly Diagnosed Brain Metastases From Kidney Cancer, Melanoma, or Sarcoma
Eastern Cooperative Oncology Group
Phase 2 Completed
NCT00002997 2023-06-15
Cryosurgery in Treating Patients With Unresectable Liver Metastases From Colorectal Cancer
Eastern Cooperative Oncology Group
Phase 2 Completed
NCT01746225 2023-06-01
SNAP
ETOP IBCSG Partners Foundation
Phase 2 Completed
NCT02773524 2022-01-13
INTEGRATEIIa
Australasian Gastro-Intestinal Trials Group
Phase 3 Unknown
NCT00134056 2021-10-27
S0421, Docetaxel and Prednisone With or Without Atrasentan in Treating Patients With Stage IV Prostate Cancer and Bone Metastases That Did Not Respond to Previous Hormone Therapy
SWOG Cancer Research Network
Phase 3 Completed
NCT00023868 2020-12-02
Combination Chemotherapy With or Without Chemoembolization in Treating Patients With Colorectal Cancer Metastatic to the Liver (6655)
American College of Radiology Imaging Network
Phase 3 Terminated
NCT00007007 2020-10-22
Evaluation of Memory Skills in Patients Receiving Radiation Therapy for Brain Metastases
Radiation Therapy Oncology Group
Phase NA Completed
NCT00031967 2020-10-22
Melatonin and Radiation Therapy in Treating Patients With Brain Metastases
Radiation Therapy Oncology Group
Phase 2 Completed
NCT00026247 2019-07-05
ACRIN-6661
American College of Radiology Imaging Network
Phase NA Completed
NCT02129556 2019-02-15
PANACEA
ETOP IBCSG Partners Foundation
Phase 1/2 Completed
NCT01015560 2018-08-09
S0916, MLN1202 in Treating Patients With Bone Metastases
SWOG Cancer Research Network
Phase 2 Completed
NCT02066675 2018-04-11
TR1US
Italian Sarcoma Group
Phase 2 Completed
NCT01227954 2017-09-27
Avoiding the Hippocampus During Whole-Brain Radiation Therapy in Treating Patients With Brain Metastases
Radiation Therapy Oncology Group
Phase 2 Completed
NCT00566852 2017-08-21
Memantine in Preventing Side Effects in Patients Undergoing Whole-Brain Radiation Therapy for Brain Metastases From Solid Tumors
Radiation Therapy Oncology Group
Phase 3 Completed
NCT00410813 2017-07-02
S0622, Dasatinib in Treating Patients With Stage IV Breast Cancer That Has Spread to the Bone
SWOG Cancer Research Network
Phase 2 Completed
NCT00958321 2017-05-24
Positron Emission Tomography and Computed Tomography in Planning Treatment for Patients Undergoing 3-Dimensional Conformal Radiation Therapy for Non-Small Cell Lung Cancer That Cannot Be Removed by Surgery. ICORG 06-35
Cancer Trials Ireland
Phase 2 Terminated
NCT02856867 2017-05-09
MEGAN
European Organisation for Research and Treatment of Cancer - EORTC
Phase 2 Withdrawn
NCT00318110 2016-07-26
Matched Unrelated Donor Transplant for Metastatic Renal Cell Carcinoma
Center for International Blood and Marrow Transplant Research
Phase 2 Terminated
NCT01658527 2016-06-10
TAK-700 in Castration Resistant Prostate Cancer
European Organisation for Research and Treatment of Cancer - EORTC
Phase 2 Withdrawn
NCT00003162 2015-11-17
Radiation Therapy in Treating Patients With Bone Metastases From Breast or Prostate Cancer
Radiation Therapy Oncology Group
Phase 3 Completed
NCT00255814 2015-11-17
Radiation Therapy in Treating Patients With Liver Metastases
Radiation Therapy Oncology Group
Phase 1 Completed
NCT00066365 2015-03-30
Inhaled Sargramostim in Treating Patients With First Pulmonary (Lung) Recurrence of Osteosarcoma
Children's Oncology Group
Phase 2 Completed
NCT00002708 2013-11-19
Radiation Therapy With or Without Radiosurgery in Treating Patients With Brain Metastases
Radiation Therapy Oncology Group
Phase 3 Completed
NCT00301886 2013-11-13
S0308 Zoledronate or Ibandronate in Preventing Bone Problems in Women With Stage IV Breast Cancer That Has Spread to the Bone
SWOG Cancer Research Network
Phase 3 Withdrawn
NCT00268463 2013-05-15
Oxaliplatin and Capecitabine With or Without an Hepatic Arterial Infusion With Floxuridine in Treating Patients Who Are Undergoing Surgery and/or Ablation for Liver Metastases Due to Colorectal Cancer
NSABP Foundation Inc
Phase 3 Terminated
NCT01189227 2013-05-10
Combination Chemotherapy Before or After Surgery in Treating Patients With Colorectal Cancer With Liver Metastases That Could Be Removed By Surgery
NSABP Foundation Inc
Phase 3 Terminated
NCT00003911 2013-01-31
S9903: Whole Brain Radiotherapy Followed By Stereotactic Radiosurgery for Limited Malignant Melanoma Brain Metastases
SWOG Cancer Research Network
Phase 2 Terminated
NCT00118105 2013-01-03
S0408: Capecitabine, Oxaliplatin, and Bevacizumab in Pts Undergoing Surgery for Liver Mets From Colorectal Cancer
SWOG Cancer Research Network
Phase 2 Withdrawn
NCT00100789 2012-10-01
S0329, Gemcitabine and Paclitaxel in Treating Patients With Persistent, Recurrent, or Metastatic Head and Neck Cancer
SWOG Cancer Research Network
Phase 2 Completed
NCT00003941 2012-09-24
Combination Chemotherapy With or Without Peripheral Stem Cell Transplant in Treating Men With Previously Untreated Germ Cell Cancer
European Organisation for Research and Treatment of Cancer - EORTC
Phase 3 Completed
NCT00020839 2012-09-24
Temozolomide With or Without Radiation Therapy to the Brain in Treating Patients With Stage IV Melanoma That Is Metastatic to the Brain
European Organisation for Research and Treatment of Cancer - EORTC
Phase 3 Terminated
NCT00043004 2012-09-24
Chemotherapy and Bevacizumab With or Without Radiofrequency Ablation in Treating Unresectable Liver Metastases in Patients With Colorectal Cancer
European Organisation for Research and Treatment of Cancer - EORTC
Phase 2 Terminated
NCT00110123 2012-09-24
Intravenous or Hepatic Arterial Infusion of Fotemustine in Treating Patients With Unresectable Liver Metastases From Eye Melanoma
European Organisation for Research and Treatment of Cancer - EORTC
Phase 3 Terminated